Penbrook Management’s CAS Medical Systems, Inc. CASM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-11,200
| Closed | -$27K | – | 113 |
|
|
2019
Q1 | $27K | Sell |
11,200
-11,200
| -50% | -$24.1K | 0.03% | 107 |
|
|
2018
Q4 | $36K | Hold |
22,400
| – | – | 0.04% | 104 |
|
|
2018
Q3 | $51K | Hold |
22,400
| – | – | 0.05% | 107 |
|
|
2018
Q2 | $44K | Hold |
22,400
| – | – | 0.04% | 107 |
|
|
2018
Q1 | $28K | Sell |
22,400
-11,200
| -33% | -$12.6K | 0.03% | 106 |
|
|
2017
Q4 | $26K | Buy |
+33,600
| New | +$24.6K | 0.02% | 105 |
|
|
2016
Q3 | $81K | Hold |
46,800
| – | – | 0.09% | 103 |
|
|
2016
Q2 | $86K | Hold |
46,800
| – | – | 0.09% | 103 |
|
|
2016
Q1 | $66K | Hold |
46,800
| – | – | 0.07% | 103 |
|
|
2015
Q4 | $83K | Sell |
46,800
-11,200
| -19% | -$15.8K | 0.09% | 112 |
|
|
2015
Q3 | $72K | Hold |
58,000
| – | – | 0.08% | 111 |
|
|
2015
Q2 | $74K | Hold |
58,000
| – | – | 0.07% | 103 |
|
|
2015
Q1 | $77K | Hold |
58,000
| – | – | 0.07% | 111 |
|
|
2014
Q4 | $96K | Hold |
58,000
| – | – | 0.09% | 112 |
|
|
2014
Q3 | $113K | Hold |
58,000
| – | – | 0.1% | 112 |
|
|
2014
Q2 | $117K | Sell |
58,000
-60,000
| -51% | -$127K | 0.1% | 109 |
|
|
2014
Q1 | $228K | Buy |
118,000
+58,000
| +97% | +$123K | 0.11% | 108 |
|
|
2013
Q4 | $102K | Buy |
+60,000
| New | +$93.6K | 0.1% | 105 |
|
Penbrook Management's CASM Position: Q2 2019 in Review
Penbrook Management sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 11,200 shares — an estimated $27K sold.
Penbrook Management first reported a position in CASM in Q4 2013 and held it in 18 quarters. The position peaked at $228K in Q1 2014. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.
- Penbrook Management reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
- Penbrook Management sold 11,200 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $27K.
- Penbrook Management first reported a position in CAS Medical Systems, Inc. in Q4 2013 and held it in 18 quarters.
- Penbrook Management's CAS Medical Systems, Inc. position peaked at $228K in Q1 2014.
- 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.
Based on Penbrook Management's 13F filing for Q2 2019, filed 15 Jul 2019.